← FDA DRUG APPROVALS

FDA ANDA · ANDA214196

ETRAVIRINE

Sponsor: AMNEAL

APPLICATION
ANDA214196
TYPE
ANDA
ORIGINAL APPROVAL
2021-06-14
LATEST ACTION
2021-06-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription, Discontinued

Products

ETRAVIRINEPrescription
ETRAVIRINE 200MG · TABLET · ORAL
ETRAVIRINEDiscontinued
ETRAVIRINE 25MG · TABLET · ORAL
ETRAVIRINEPrescription
ETRAVIRINE 100MG · TABLET · ORAL

Approval history

2021-06-14UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →